Pharmacologic treatment of GERD: Where we are now, and where are we going?-Reference-Cited by-同舟云学术

Pharmacologic treatment of GERD: Where we are now, and where are we going?

Published:2020-09-15 Issue:1 Volume:1482 Page:193-212
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann. N.Y. Acad. Sci.

Author:

Scarpignato Carmelo¹²,Hongo Michio³,Wu Justin C. Y.⁴,Lottrup Christian⁵⁶,Lazarescu Adriana⁷,Stein Ellen⁸,Hunt Richard H.⁹

Affiliation:

1. Department of Health Sciences United Campus of Malta Msida Malta

2. Faculty of Medicine Chinese University of Hong Kong Shatin Hong Kong

3. Department of Comprehensive Medicine Tohoku University Sendai Miyagi Japan

4. Department of Medicine and Therapeutics Prince of Wales Hospital Shatin Hong Kong China

5. Department of Medicine Aalborg University Hospital Hobro Denmark

6. Mech‐Sense, Department of Gastroenterology & Hepatology Aalborg University Hospital Aalborg Denmak

7. Division of Gastroenterology University of Alberta Edmonton Alberta Canada

8. Division of Gastroenterology and Hepatology Johns Hopkins University Baltimore Maryland

9. Division of Gastroenterology and Farncombe Family Digestive Health Research Institute, Department of Medicine McMaster University Hamilton Ontario Canada

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nyas.14473

Reference194 articles.

1. GERD pathogenesis, pathophysiology, and clinical manifestations.

2. An evidence-based appraisal of reflux disease management --- the Genval Workshop Report

3. The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus

4. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review

5. Gastro-oesophageal reflux disease in primary care

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label, Single-Center, Multiple-Dosage, Self-Controlled, Phase I Trial;Clinical Drug Investigation;2024-04-13

2. GERD: Latest update on acid-suppressant drugs;Current Research in Pharmacology and Drug Discovery;2024

3. Keverprazan, a novel potassium-competitive acid blocker: Single ascending dose safety, tolerability, pharmacokinetics, pharmacodynamics and food effect in healthy subjects;European Journal of Pharmaceutical Sciences;2023-11

4. Efficacy of 14-day vonoprazan-amoxicillin dual therapy compared to esomeprazole-amoxicillin dual therapy for eradication of Helicobacter pylori in treatment-naïve patients;2023-09-14

5. A comparison of different symptomatic reflux esophagitis treatments: A real-world study;Advances in Clinical and Experimental Medicine;2023-09-04